Summit Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $18M | 7.0M | 2.61 |
| 2023-09-30 | $11M | 6.1M | 1.87 |
| 2023-06-30 | $15M | 6.1M | 2.51 |
| 2023-03-31 | $2.6M | 1.5M | 1.75 |
| 2022-12-31 | $6.1M | 1.4M | 4.25 |
| 2022-06-30 | $776k | 776k | 1.00 |
| 2022-03-31 | $2.2M | 911k | 2.45 |
| 2021-09-30 | $4.5M | 906k | 5.01 |
| 2021-06-30 | $6.6M | 880k | 7.47 |
| 2021-03-31 | $3.2M | 550k | 5.87 |
| 2020-12-31 | $2.6M | 550k | 4.70 |